156 related articles for article (PubMed ID: 34480937)
1. Berberine combined with stachyose improves glycometabolism and gut microbiota through regulating colonic microRNA and gene expression in diabetic rats.
Li C; Cao H; Huan Y; Ji W; Liu S; Sun S; Liu Q; Lei L; Liu M; Gao X; Fu Y; Li P; Shen Z
Life Sci; 2021 Nov; 284():119928. PubMed ID: 34480937
[TBL] [Abstract][Full Text] [Related]
2. Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice.
Li CN; Wang X; Lei L; Liu MZ; Li RC; Sun SJ; Liu SN; Huan Y; Zhou T; Liu Q; Cao H; Bai GL; Han YW; Shen ZF
Phytother Res; 2020 May; 34(5):1166-1174. PubMed ID: 31833107
[TBL] [Abstract][Full Text] [Related]
3. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.
Wang Y; Liu H; Zheng M; Yang Y; Ren H; Kong Y; Wang S; Wang J; Jiang Y; Yang J; Shan C
Front Endocrinol (Lausanne); 2021; 12():609134. PubMed ID: 34025574
[TBL] [Abstract][Full Text] [Related]
4. Cocoa diet modulates gut microbiota composition and improves intestinal health in Zucker diabetic rats.
Álvarez-Cilleros D; Ramos S; López-Oliva ME; Escrivá F; Álvarez C; Fernández-Millán E; Martín MÁ
Food Res Int; 2020 Jun; 132():109058. PubMed ID: 32331673
[TBL] [Abstract][Full Text] [Related]
5. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
6. Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis.
Wu YS; Chen YT; Bao YT; Li ZM; Zhou XJ; He JN; Dai SJ; Li CY
PLoS One; 2016; 11(11):e0166378. PubMed ID: 27846294
[TBL] [Abstract][Full Text] [Related]
7. Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice.
Cao H; Li C; Lei L; Wang X; Liu S; Liu Q; Huan Y; Sun S; Shen Z
Front Pharmacol; 2020; 11():578943. PubMed ID: 33192521
[TBL] [Abstract][Full Text] [Related]
8. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats.
Mao ZJ; Weng SY; Lin M; Chai KF
J Ethnopharmacol; 2019 Oct; 243():111966. PubMed ID: 31128151
[TBL] [Abstract][Full Text] [Related]
9. Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats.
Zhao JD; Li Y; Sun M; Yu CJ; Li JY; Wang SH; Yang D; Guo CL; Du X; Zhang WJ; Cheng RD; Diao XC; Fang ZH
World J Gastroenterol; 2021 Feb; 27(8):708-724. PubMed ID: 33716449
[TBL] [Abstract][Full Text] [Related]
10. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD
Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947
[TBL] [Abstract][Full Text] [Related]
11. Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway.
Wu YS; Li ZM; Chen YT; Dai SJ; Zhou XJ; Yang YX; Lou JS; Ji LT; Bao YT; Xuan L; Lin LN; Li CY
J Immunol Res; 2020; 2020():2141508. PubMed ID: 32908938
[TBL] [Abstract][Full Text] [Related]
12. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice.
Zhang W; Xu JH; Yu T; Chen QK
Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226
[TBL] [Abstract][Full Text] [Related]
13. Stachyose Improves Inflammation through Modulating Gut Microbiota of High-Fat Diet/Streptozotocin-Induced Type 2 Diabetes in Rats.
Liu G; Bei J; Liang L; Yu G; Li L; Li Q
Mol Nutr Food Res; 2018 Mar; 62(6):e1700954. PubMed ID: 29341443
[TBL] [Abstract][Full Text] [Related]
14. MiR-34a-5p and miR-452-5p: The Novel Regulators of Pancreatic Endocrine Dysfunction in Diabetic Zucker Rats?
Su T; Hou J; Liu T; Dai P; Qin L; Ding L; Hu Y; Guo X
Int J Med Sci; 2021; 18(14):3171-3181. PubMed ID: 34400887
[No Abstract] [Full Text] [Related]
15. Intestinal bile acid sequestration improves glucose control by stimulating hepatic miR-182-5p in type 2 diabetes.
Sedgeman LR; Beysen C; Allen RM; Ramirez Solano MA; Turner SM; Vickers KC
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G810-G823. PubMed ID: 30160993
[TBL] [Abstract][Full Text] [Related]
16. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
[TBL] [Abstract][Full Text] [Related]
17. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine.
Zhang Q; Xiao X; Li M; Li W; Yu M; Zhang H; Ping F; Wang Z; Zheng J
BMC Complement Altern Med; 2014 Jun; 14():188. PubMed ID: 24912407
[TBL] [Abstract][Full Text] [Related]
18. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
19. Urinary metabolomics analysis reveals the anti-diabetic effect of stachyose in high-fat diet/streptozotocin-induced type 2 diabetic rats.
Liang L; Liu G; Yu G; Zhang F; Linhardt RJ; Li Q
Carbohydr Polym; 2020 Feb; 229():115534. PubMed ID: 31826396
[TBL] [Abstract][Full Text] [Related]
20. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe
Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X
Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
